Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tdon1229on Oct 09, 2020 3:26pm

203 Views

Post# 31696906

RE:RE:Big let down

The way I see it is they burrned through the money from the last raise that was earmarked for the new indication Phase I, so that's not an option with the current money on hand ... they'll need another raise just to start that ... but (mis)mgmt got (over)paid during the COVID shutdown and the undertreatment of the first 12 patients in the Phase II.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario